HK1198699A1 - 誘導抗原特異性 細胞耐受的抗體及其用途 - Google Patents

誘導抗原特異性 細胞耐受的抗體及其用途

Info

Publication number
HK1198699A1
HK1198699A1 HK14112219.4A HK14112219A HK1198699A1 HK 1198699 A1 HK1198699 A1 HK 1198699A1 HK 14112219 A HK14112219 A HK 14112219A HK 1198699 A1 HK1198699 A1 HK 1198699A1
Authority
HK
Hong Kong
Prior art keywords
olerance
specific cell
inducing antigen
antibody inducing
use hereof
Prior art date
Application number
HK14112219.4A
Other languages
English (en)
Inventor
朴聖會
鄭景天
Original Assignee
Dinona Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dinona Inc filed Critical Dinona Inc
Publication of HK1198699A1 publication Critical patent/HK1198699A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2821—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against ICAM molecules, e.g. CD50, CD54, CD102
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • C12N5/16—Animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • C12N5/16—Animal cells
    • C12N5/163—Animal cells one of the fusion partners being a B or a T lymphocyte

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Transplantation (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK14112219.4A 2011-07-05 2014-12-04 誘導抗原特異性 細胞耐受的抗體及其用途 HK1198699A1 (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/KR2011/004908 WO2013005873A1 (en) 2011-07-05 2011-07-05 An antibody inducing antigen-specific t cell tolerance and use thereof

Publications (1)

Publication Number Publication Date
HK1198699A1 true HK1198699A1 (zh) 2015-06-19

Family

ID=47437205

Family Applications (1)

Application Number Title Priority Date Filing Date
HK14112219.4A HK1198699A1 (zh) 2011-07-05 2014-12-04 誘導抗原特異性 細胞耐受的抗體及其用途

Country Status (13)

Country Link
US (1) US8900586B2 (zh)
EP (1) EP2729497B1 (zh)
JP (1) JP5890017B2 (zh)
KR (1) KR20140026567A (zh)
CN (1) CN103842381B (zh)
AU (1) AU2011372348B2 (zh)
BR (1) BR112014000044B8 (zh)
CA (1) CA2844532C (zh)
ES (1) ES2602781T3 (zh)
HK (1) HK1198699A1 (zh)
IL (1) IL230172A (zh)
MX (1) MX347439B (zh)
WO (1) WO2013005873A1 (zh)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101434029B1 (ko) * 2012-09-14 2014-08-26 서울대학교산학협력단 Ｉｃａｍ－1에 대한 항체 및 그 용도
KR102063341B1 (ko) * 2018-12-31 2020-01-07 다이노나(주) Icam-1에 특이적으로 결합하는 항체 및 그의 용도

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9009549D0 (en) * 1990-04-27 1990-06-20 Celltech Ltd Recombinant antibody and method
US8026343B2 (en) * 2008-08-08 2011-09-27 Dinona Inc. Antibody modulating the differentiation and function of dendritic cells via binding intercellular adhesion molecule-1 and use thereof

Also Published As

Publication number Publication date
CN103842381A (zh) 2014-06-04
IL230172A (en) 2017-04-30
EP2729497B1 (en) 2016-08-17
CA2844532A1 (en) 2013-01-10
MX347439B (es) 2017-04-26
US8900586B2 (en) 2014-12-02
AU2011372348B2 (en) 2015-04-30
BR112014000044B1 (pt) 2021-03-16
WO2013005873A1 (en) 2013-01-10
BR112014000044A2 (pt) 2017-02-21
CN103842381B (zh) 2016-06-08
BR112014000044B8 (pt) 2023-03-21
MX2014000186A (es) 2014-05-30
KR20140026567A (ko) 2014-03-05
EP2729497A1 (en) 2014-05-14
US20140148583A1 (en) 2014-05-29
CA2844532C (en) 2016-10-11
JP2014522831A (ja) 2014-09-08
JP5890017B2 (ja) 2016-03-22
AU2011372348A1 (en) 2014-02-27
ES2602781T3 (es) 2017-02-22
EP2729497A4 (en) 2015-01-14

Similar Documents

Publication Publication Date Title
HUS2100034I1 (hu) ANGPTL3-ellenes antitestek és alkalmazásaik
IL288203B (en) Meditops and Meditop binding antibodies and their use
IL281250A (en) Anti-PHF-tau antibodies and uses thereof
HK1243344A1 (zh) 抗體製劑和方法
IL232399A0 (en) Anti-2fgfr antibodies and their use
EP2701278A4 (en) CHARGING DEVICE AND CHARGING METHOD
EP2756094A4 (en) ANTI-B7-H4 ANTIBODIES AND USES THEREOF
HK1199842A1 (zh) 抗涎免凝集素- 抗體及其用途
HK1198699A1 (zh) 誘導抗原特異性 細胞耐受的抗體及其用途
SG10201605510SA (en) An antibody inducing antigen-specific t cell tolerance and use thereof
SG10201709012TA (en) An antibody inducing antigen-specific t cell tolerance and use thereof